Detalhe da pesquisa
1.
The Effect of Systemic Parameters and Baseline Characteristics in Short-Term Response Analysis with Intravitreal Ranibizumab in Treatment-Naive Patients with Neovascular Age-Related Macular Degeneration.
Pharmaceutics
; 16(1)2024 Jan 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38258115
2.
Relationships between Patient-Reported Outcome Measures and Clinical Measures in Naïve Neovascular Age-Related Macular Degeneration Patients Treated with Intravitreal Ranibizumab.
Pharmaceuticals (Basel)
; 17(2)2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38399372
3.
Influence of Genetic Polymorphisms on the Short-Term Response to Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration.
Invest Ophthalmol Vis Sci
; 64(13): 34, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37862026
4.
The role of retinal fluid location in atrophy and fibrosis evolution of patients with neovascular age-related macular degeneration long-term treated in real world.
Acta Ophthalmol
; 100(2): e521-e531, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34085771
5.
Pharmacological Advances in the Treatment of Age-related Macular Degeneration.
Curr Med Chem
; 27(4): 583-598, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31362645
6.
Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.
Am J Ophthalmol
; 142(2): 335-7, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16876524